Wells Fargo
MNTA

Wells Fargo’s Momenta Pharmaceuticals, Inc. MNTA Stock Holding History

Wells Fargo’s Portfolio MNTA Stock Details MNTA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-19,700
Closed -$30K – 6441
2016
Q2 		$30K Buy
+19,700
New +$203K ﹤0.01% 5380

Wells Fargo's MNTA Position: Q4 2020 in Review

Wells Fargo sold out of Momenta Pharmaceuticals, Inc. (MNTA) in Q4 2020, closing a stake of 116,487 shares — an estimated $6.11M sold.

Wells Fargo first reported a position in MNTA in Q2 2013 and held it in 30 quarters. The position peaked at $6.54M in Q2 2020. 0 funds tracked by Wall St. Rank hold MNTA as of Q4 2020.

  • Wells Fargo reported no remaining Momenta Pharmaceuticals, Inc. position as of Q4 2020 after selling out during the quarter.
  • Wells Fargo sold 116,487 Momenta Pharmaceuticals, Inc. shares in Q4 2020, an estimated $6.11M.
  • Wells Fargo first reported a position in Momenta Pharmaceuticals, Inc. in Q2 2013 and held it in 30 quarters.
  • Wells Fargo's Momenta Pharmaceuticals, Inc. position peaked at $6.54M in Q2 2020.
  • 0 funds tracked by Wall St. Rank held Momenta Pharmaceuticals, Inc. as of Q4 2020.

Based on Wells Fargo's 13F filing for Q4 2020, filed 9 Feb 2021.